Literature DB >> 11548876

Abnormal myocardial free fatty acid utilization deteriorates with morphological changes in the hypertensive heart.

H Nakayama1, T Morozumi, S Nanto, T Shimonagata, T Ohara, Y Takano, J Kotani, T Watanabe, M Fujita, M Nishio, H Kusuoka, M Hori, S Nagata.   

Abstract

The left ventricle's morphological adaptation to high blood pressure is classified into 4 patterns based on mass and wall thickness. The geometric changes caused by maladaptation to pressure overload possibly relate to progression of contractile dysfunction with abnormal energy metabolism. The present study assessed whether the geometric adaptation of the left ventricle (LV) to high blood pressure relates to changes in myocardial energy metabolism, especially free fatty acid (FFA) utilization. Thirty-five patients with essential hypertension underwent echocardiography and dual isotopes myocardial scintigraphy using iodine-123 labeled 15-p-iodophenyl-3-(R,S)-methylpentadecanoic acid (BMIPP, an analogue of a FFA) and thallium-201 (Tl-201). Systolic (endocardial fractional shortening; %FS) and diastolic indices (the ratio of early to atrial filling waves; E/A) of LV function were also assessed. Quantitative myocardial BMIPP uptake was evaluated by the BMIPP/TI-201 myocardial uptake ratio (B/T). The subjects were divided into 4 groups based on LV mass and wall thickness: (1) concentric hypertrophy (CH), (2) eccentric hypertrophy (EH), (3) concentric remodeling (CR), and (4) normal geometry (N). The %FS was lower in the EH group than in the other groups. The mitral E/A ratio in the CH group was lowest. B/T was significantly decreased in the EH group compared with the N group (p < 0.05). B/T correlated with the mitral E/A ratio significantly (p < 0.05, r = 0.42), whereas there was no relationship between %FS and B/T. These results indicate that the geometric changes occurring in hypertensive hearts strongly correlate with alternations in cardiac function and with abnormal myocardial FFA metabolism, and that the latter is associated with diastolic abnormality, but not with systolic function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11548876     DOI: 10.1253/jcj.65.783

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  11 in total

1.  Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.

Authors:  Lisa de las Fuentes; Pablo F Soto; Brian P Cupps; Michael K Pasque; Pilar Herrero; Robert J Gropler; Alan D Waggoner; Victor G Dávila-Román
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

2.  A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.

Authors:  Cheng-Yang Wu; Santhosh Satapati; Wenjun Gui; R Max Wynn; Gaurav Sharma; Mingliang Lou; Xiangbing Qi; Shawn C Burgess; Craig Malloy; Chalermchai Khemtong; A Dean Sherry; David T Chuang; Matthew E Merritt
Journal:  J Biol Chem       Date:  2018-05-08       Impact factor: 5.157

Review 3.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

4.  MOB1-YAP1/TAZ-NKX2.1 axis controls bronchioalveolar cell differentiation, adhesion and tumour formation.

Authors:  K Otsubo; H Goto; M Nishio; K Kawamura; S Yanagi; W Nishie; T Sasaki; T Maehama; H Nishina; K Mimori; T Nakano; H Shimizu; T W Mak; K Nakao; Y Nakanishi; A Suzuki
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

Review 5.  Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Authors:  Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

6.  Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function.

Authors:  Jyh-Ming Jimmy Juang; Lisa de Las Fuentes; Alan D Waggoner; C Charles Gu; Víctor G Dávila-Román
Journal:  BMC Med Genet       Date:  2010-04-28       Impact factor: 2.103

7.  Free fatty acids are associated with pulse pressure in women, but not men, with type 1 diabetes mellitus.

Authors:  Baqiyyah Conway; Rhobert W Evans; Linda Fried; Sheryl Kelsey; Daniel Edmundowicz; Trevor J Orchard
Journal:  Metabolism       Date:  2009-07-01       Impact factor: 8.694

Review 8.  [Diabetic cardiomyopathy--a type of coronary artery disease?].

Authors:  B Stratmann; I Stork; D Tschoepe
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

9.  Role of differential signaling pathways and oxidative stress in diabetic cardiomyopathy.

Authors:  Kenichi Watanabe; Rajarajan A Thandavarayan; Meilei Harima; Flori R Sari; Narasimman Gurusamy; Punniyakoti T Veeraveedu; Sayaka Mito; Wawaimuli Arozal; Vijayakumar Sukumaran; Arun Prasath Laksmanan; Vivian Soetikno; Makoto Kodama; Yoshifusa Aizawa
Journal:  Curr Cardiol Rev       Date:  2010-11

10.  Effects of insulin therapy on myocardial lipid content and cardiac geometry in patients with type-2 diabetes mellitus.

Authors:  Drazenka Jankovic; Yvonne Winhofer; Miriam Promintzer-Schifferl; Evelyne Wohlschläger-Krenn; Christian Heinz Anderwald; Peter Wolf; Thomas Scherer; Gert Reiter; Siegfried Trattnig; Anton Luger; Michael Krebs; Martin Krssak
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.